Locus Biosciences 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LBP-EC01 / Locus Biosciences
ELIMINATE, NCT05488340: A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli ( Trial)

Recruiting
2
318
US
LBP-EC01 0.1 x IV dose, 1x10^11 PFU IV dose, LBP-EC01 0.01x IV Dose, 1x10^10 PFU IV Dose, LBP-EC01 IV Infusion Dose, 1x10^12 PFU IV Infusion Dose, Placebo, LBP-EC01, TMP/SMX
Locus Biosciences, Parexel
Urinary Tract Infections
06/25
12/25

Download Options